Boston Scientific Corp (BSX)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	1,591,000	1,282,000	966,000	956,000	752,000	653,000	884,000	810,000	1,041,000	884,000	310,000	-23,000	-353,000	-514,000	-233,000	68,000	481,000	614,000	920,000	1,321,000
Total assets	US$ in thousands	35,136,000	34,043,000	33,601,000	32,892,000	32,469,000	31,947,000	32,189,000	32,337,000	32,229,000	31,877,000	31,168,000	30,900,000	30,777,000	30,845,000	30,823,000	30,113,000	30,565,000	26,756,000	24,309,000	23,802,000
ROA		4.53%	3.77%	2.87%	2.91%	2.32%	2.04%	2.75%	2.50%	3.23%	2.77%	0.99%	-0.07%	-1.15%	-1.67%	-0.76%	0.23%	1.57%	2.29%	3.78%	5.55%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,591,000K ÷ $35,136,000K
= 4.53%

Boston Scientific Corp.'s return on assets (ROA) has shown some variability over the past eight quarters, ranging from a low of 1.87% in Q3 2022 to a high of 4.47% in Q4 2023. On average, the company has achieved an ROA of 2.69% over this period. A rising trend in ROA from Q1 2022 to Q4 2023 indicates an improvement in the company's ability to generate profits from its assets. This suggests that Boston Scientific Corp. has been effectively utilizing its assets to generate earnings for its shareholders, reflecting positively on the company's operational efficiency and financial performance. However, it is important to continue monitoring changes in ROA to assess the sustainability of this performance in the long term.